Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4Head & Neck 1

Conditions

Ovarian Neoplasms 29Uterine Cervical Neoplasms 23Endometrial Neoplasms 14Breast Neoplasms 10Neoplasms 8Uterine Cervical Dysplasia 5Carcinoma, Ovarian Epithelial 5Peritoneal Neoplasms 4Papillomavirus Infections 4Lung Neoplasms 4Fallopian Tube Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Hereditary Breast and Ovarian Cancer Syndrome 3Disease 3Uterine Neoplasms 2Prostatic Neoplasms 2Primary Ovarian Insufficiency 2Ovarian Diseases 2Melanoma 2Leukemia 2Kidney Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Hyperplasia 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 16Papillomavirus Vaccines 12Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Vaccines 5Human Papillomavirus DNA Tests 5Colposcopy 5Specimen Handling 4Blood Specimen Collection 4Watchful Waiting 3Vaginal Smears 3Patient Navigation 3Engerix-B 3Educational Status 3fludarabine phosphate 2fludarabine 2artesunic acid 2artemisinin 2aldesleukin 2Vaccines, Synthetic 2Standard of Care 2Practice Guidelines as Topic 2Polymerase Chain Reaction 2Mass Screening 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine nonavalent 2GX-188 vaccine 2Early Intervention, Educational 2Data Collection 2Cyclophosphamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Papillomavirus Infections × Blood Specimen Collection × Gynecologic × Clear all
NCT06129253 2025-07-16

HPV

International Vaccine Institute

Recruiting
29,750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00947115 2020-10-30

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

GlaxoSmithKline

Phase 3 Completed
525 enrolled 24 charts
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00877877 2020-01-18

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

GlaxoSmithKline

Phase 3 Completed
632 enrolled 28 charts
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00929526 2016-10-20

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

GlaxoSmithKline

Phase 3 Completed
752 enrolled 21 charts
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡